In hepatocellular carcinoma, KLF4 directly activated EpCAM, increased the number of EpCAM+/CD133+ liver cancer stem cells in vitro, and amplified the tumorigenesis in vivo [84]. Here, KLF4 is linked to hepatocellular carcinoma.